Mindset Pharma Inc. (MSSTF) Research

Mindset Pharma Inc., headquartered in Toronto, Canada, specializes in researching, developing, and commercializing psychedelic therapeutics. These innovative treatments are designed to address neurological and psychiatric conditions for patients in Canada. A primary focus for the company is the ongoing development of MSP-1014, an investigational psychedelic compound.

Market snapshot

Symbol
MSSTF
Price
$0.54
Day change
-0.37%
Market cap
$75.0M
P/E ratio
-4.01x
52-week range
0.1626-0.559
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Biostage, Inc. (BSTG)
  • Healthcare Integrated Technologies, Inc. (HITC)
  • Herantis Pharma Oyj (HRPMF)
  • INNOCAN PHARMA Corp (INNPF)
  • Karolinska Development AB (publ) (KDEVF)
  • MCI Onehealth Technologies Inc. (MCIOF)
  • Medivir AB (publ) (MVRBF)
  • Abliva AB (publ) (NEVPF)

Open Mindset Pharma Inc. (MSSTF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.